DYRK2 and breast carcinoma: As part of a regulatory feedback loop, DYRK2 enhances proteasomal degradation via phosphorylation of the 19S subunit Rpt3 during the cell cycle; thus, loss of DYRK2 inhibits tumor formation by breast cancer cell lines84.